Cholinergic hypothesis in psychosis following traumatic brain injury and cholinergic hypothesis in schizophrenia: A link?;Théorie cholinergique dans les psychoses après un traumatisme crânien et dans la schizophrénie: Un lien?

Encephale

Volumn 33, Issue 4 C1, 2007, Pages 616-620

  Bennouna, M ^a   Greene, V B ^b   Defranoux, L ^a  

^a CHS de Sarreguemines   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Acetylcholine; Acetylcholinesterase inhibitors; Galantamine; Schizophrenia; Schizophrenia like psychosis; Traumatic brain injury

Indexed keywords

ACETYLCHOLINESTERASE; BUNGAROTOXIN RECEPTOR; CHOLINESTERASE INHIBITOR; CLOZAPINE; DOPAMINE; GALANTAMINE; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 4; NEOSTIGMINE; RISPERIDONE; RIVASTIGMINE; SEROTONIN;

AUDITORY STIMULATION; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; COMPETITIVE INHIBITION; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; EVOKED RESPONSE; FRONTAL CORTEX; FRONTAL LOBE; HUMAN; MENTAL PATIENT; PARIETAL LOBE; POSITIVE SYNDROME; PSYCHOSIS; REVIEW; RISK FACTOR; SCHIZOPHRENIA; TRAUMATIC BRAIN INJURY;

EID: 35348823144     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0013-7006(07)92062-x     Document Type: Review

References (43)

1. AASEN I, KUMARI V, SHARMA T. Effects of rivastigmine on sustained attention in schizophrenia : an FMRI study. J Clin Psychopharmacol 2005 ; 25 (4) : 311-7.
2. ACHTE K, JARHO L, KYYKAA T et al. Paranoid disorders following war brain damage. Preliminary report. Psychopathology 1991 ; 24 (5) : 309-15.
3. ACHTE K. Psychoses following war brain injuries. Acta Psychiatr Scand 1969 ; 45 (1) : 1-18.
4. ALLEN TB, McEVOY JP, KEEFE R et al. Galantamine as an adjunctive therapy in the treatment of schizophrenia. Presented at 11th Congress of the International Psychogeriatric Association (IPA), Chicago, 2003 Aug : 17-22.
5. ALLEN TB, McEVOY JP. Galantamine for treatment-resistant schizophrenia. Am J Psychiatry 2002 ; 159 (7) : 1244-5.
6. ARCINIEGAS DB, TOPKOFF J, SILVER JM. Neuropsychiatric aspects of traumatic brain injury. Curr Treat Opt Neurol 2000 ; 2 (2) : 169-86.
7. ARCINIEGAS DB. The cholinergic hypothesis of cognitive impairment caused by traumatic brain injury. Curr Psychiatr Rep 2003 ; 5 (5) : 391-9.
8. ARNOLD DS, ROSSE RB, DICKINSON D et al. Adjuvant therapeutic effects of galantamine on apathy in a schizophrenia patient. Clin Psychiatry 2004 ; 65 (12) : 1723-4.
9. BENNOUNA M, GREENE VB, DEFRANOUX L. Adjuvant galantamine to risperidone improves negative and cognitive symptoms in a patient presenting with schizophrenia like psychosis after traumatic brain injury. J Clin Psychopharmacol 2005 ; 25 (5) : 505-7.
10. BORA E, VEZNEDAROGLU B, KAYAHAN B. The effect of galantamine added to clozapine on cognition of five patients with schizophrenia. Clin Neuropharmacol 2005 ; 28 (3) : 139-41.
11. BUTLER PV. Diurnal variation in Cotard's syndrome copresent with Capgras delusion following traumatic brain injury. Austr N Zeal J Psychiatry 2000 ; 34 : 684-7.
12. CHEN Y, SHOHAMI E, CONSTANTINI S et al. Rivastigmine, a brain-selective acetylcholinesterase inhibitor, ameliorates cognitive and motor deficits induced by closed-head injury in the mouse. J Neurotrauma 1998 ; 15 (4) : 231-7.
13. CROOK JM, TOMASLOVIC-CROOK E, COPOLOV DL et al. Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia : a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment. Am J Psychiatry 2001 ; 158 (6) : 918-25.
14. DAVISON K, BAGLEY CR. Schizophrenia-like psychosis associated with organic disorders of the central nervous system. Br J Psychiatry 1969 ; 114 : 113-84.
15. DEWAR D, GRAHAM DI. Depletion of choline acetyltransferase but preservation of M1 and M2 muscarinic receptor bindingsites in temporal cortex following head injury : a preliminary human postmortem study. J Neurotrauma 1996 ; 13 : 181-7.
16. DIXON CE, MA X, MARION DW. Reduced evoked release of acetylcholine in the rodent neocortex following traumatic brain injury. Brain Res 1997 ; 749 : 127-30.
17. DRIMER T, SHAHAL B, BARAK Y. Effects of discontinuation of long-term anticholinergic treatment in elderly schizophrenia patients. Int Clin Psychopharmacol 2004 ; 19 (1) : 27-9.
18. FRIEDMAN JI. Cholinergic targets for cognitive enhancement in schizophrenia : focus on cholinesterase inhibitors and muscarinic agonists. Psychopharmacology (Berl) 2004 ; 174 (1) : 45-53.
19. FUJII D, AHMED I, HISHINUMA E. A neuropsychological comparison of psychotic disorder following traumatic brain injury, traumatic brain injury without psychotic disorder, and schizophrenia. J Neuropsychiatr Clin Neurosci 2004 ; 16 (3) : 306-14.
20. FUJII D, AHMED I. Characteristics of psychotic disorder due to traumatic brain injury : an analysis of case studies in the literature. J Neuropsychiatry Clin Neurosci 2002 ; 14 (2) : 130-40.
21. GUAN ZZ, ZHANG X, BLENNOW K et al. Decreased protein level of nicotinic receptor alpha 7 subunit in the frontal cortex from schizophrenic brain. Neuroreport 1999 3 ; 10 (8) : 1779-82.
22. ICHIKAWA J, DAI J, O'LAUGHLIN IA et al. Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology 2002 ; 26 (3) : 325-39.
23. KANE JM, SMITH JM. Tardive dyskinesia, prevalence and risk factors. Arch Gen Psychiatry 1982 ; 39 : 473-81.
24. KRAEPELIN E. Dememtia Praecox and the Paraphrenia. Edinburg : E. & S. Livingston, 1919.
25. LADDOMADA A, LA CROCE ML. Clozapine treatment and posttraumatic psychosis disorders, a case report. Eur Neuropsychopharmacology 1999 ; 9 : 257-8.
26. LAWRIE SM, BUECHEL C, WHALLEY HC et al. Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations. Biol Psychiatry 2002 ; 51 (12) : 1008-11.
27. LENZI A, MALTINTI E, POGGI E et al. Effects of rivastigmine on cognitive function and quality of life in patients with schizophrenia. Clin Neuropharmacol 2003 ; 26 (6) : 317-21.
28. LISHMAN WA. The psychiatric sequelae of head injury : a review. Psychol Med 1973 ; 3 (3) : 304-18.
29. LOVELL MR, FRANZEN MD. Neuropsychological assessment. In : Silver JM, Yudofsky SC, Hales RE, eds. Neuropsychiatry of Traumatic Brain Injury. Washington, DC : American Psychiatric Press Inc, 1994 : 133-60.
30. MCALLISTER TW, FERREL RB. Evaluation and treatment of psychosis after traumatic brain injury. Neuro Rehabilit 2002 ; 17 (4) : 357-68.
31. MURDOCH I, PERRY EK, COURT JA et al. Cortical cholinergic dysfunction after human head injury. J Neurotrauma 1998 ; 15 : 295-305.
32. NELSON CL, BURK JA, BRUNO JP et al. Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats. Psychopharmacology (Berl) 2002 ; 161 (2) : 168-79.
33. NOMIKOS GG, SCHILSTROM B, HILDEBRAND BE et al. Role of alpha 7 nicotinic receptors in nicotine dependence and implications for psychiatric illness. Behav Brain Res 2000 ; 113 (1-2) : 97-103.
34. POWCHIK P, DAVIDSON M, HAROUTUNIAN V et al. Post-mortem studies in schizophrenia. Schizophr Bull 1998 ; 24 (3) : 325-41.
35. RAEDLER TJ, KNABLE MB, JONES DW et al. In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia. Am J Psychiatry 2003 ; 160 (1) : 118-27.
36. RAEDLER TJ, KNABLE MB, WEINBERGER DR. Schizophrenia as a developmental disorder of the cerebral cortex. Curr Opin Neurobiol 1998 ; 8 (1) : 157-61.
37. ROSSE RB, DEUTSCH SII. Adjuvant galantamine administration improves negative symptoms in a patient with treatment-refractory schizophrenia. Clin Neuropharmacol 2002 ; 25 (5) : 272-5.
38. SCHMIDT RH, GRADY MS. Loss of forebrain cholinergic neurons following fluid-percussion injury : implications for cognitive impairment in closed head injury. J Neurosurg 1995 ; 83 : 496-502.
39. SCHREIBER S, KLAG E, GROSS Y et al. Beneficial effect of risperidone on sleep disturbance and psychosis following traumatic brain injury. Intern Clin Psychopharmacol 1998 ; 13 : 273-5.
40. TANDON R, DEQUARDO JR, GOODSON J et al. Effect of anticholinergics on positive and negative symptoms in schizophrenia. Psychopharmacol Bull 1992 ; 28 : 297-302.
41. TENOVUO O. Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury-clinical experience in 111 patients. Prog Neuropsychopharmacol Biol Psychiatry 2005 ; 29 (1) : 61-7.
42. UMANSKY R, GELER V. Olanzapine treatment in an organic hallucinosis patient. Intern J Neuropsychopharmacol 2000 ; 3 : 81-2.
43. VON FRAFT-EBING R. Ueber die durch Gehirnerschutterung und Kopfverletzung hervorgerufenen psychischen Krankheitten. Eine klinisch-forensische studie. Verlag von Ferdinand Enke : Erlangen, 1868.